![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 471/04 | (2006.01) |
C07D 471/04 | (2013.01) | ||
A61K 31/4745 | (2006.01) | ||
C07D 471/14 | (2013.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 25/28 | (2018.01) |
(11) | Number of the document | 3592740 |
(13) | Kind of document | T |
(96) | European patent application number | 18711175.2 |
Date of filing the European patent application | 2018-03-01 | |
(97) | Date of publication of the European application | 2020-01-15 |
(45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2018/051318 |
Date | 2018-03-01 |
(87) | Number | WO 2018/163030 |
Date | 2018-09-13 |
(30) | Number | Date | Country code |
201762469768 P | 2017-03-10 | US |
(72) |
CHAPPIE, Thomas Allen , US
GALATSIS, Paul , US
GARNSEY, Michelle Renee , US
HELAL, Christopher John , US
HENDERSON, Jaclyn Louise , US
KORMOS, Bethany Lyn , US
KURUMBAIL, Ravi G. , US
MARTINEZ-ALSINA, Luis Angel , US
PETTERSSON, Martin Youngjin , US
STEPAN, Antonia Friederike , DE
WAGER, Travis T. , US
|
(73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
(54) | CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES |
CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES |